Angelo Roberto Raccagni

High Prevalence of Macrolide Resistance in Mycoplasma Genitalium Supports Empiric Moxifloxacin Treatment in Men who Have Sex with Men in Milan

Angelo Roberto Raccagni, Virginia Batignani, Sara Racca, Antonella Castagna et autres

it (code pays fourni par la source)

Research news in clinical context

Angelo Roberto Raccagni, Marina Daskalopoulou, Rachel Herbert, Drieda Zaçe

it, gb, ae (code pays fourni par la source)

How do I screen for tuberculosis and provide tuberculosis preventive treatment in people with HIV?

Angelo Roberto Raccagni, Roberta Maria Antonello, Margherita Pieruzzi, Andrea Calcagno et autres

it, us (code pays fourni par la source)

Three settings, one goal: Performance of different HIV testing strategies at a tertiary centre in Milan

Angelo Roberto Raccagni, Riccardo Lolatto, Nicolò Capra, Gabriele Loi et autres

Abstract Objectives Timely HIV diagnosis remains suboptimal in Italy. The aims of this study are to assess how inpatient, outpatient and community HIV testing strategies differ in diagnostic yield, testers' demographics, immuno‐virological status at diagnosis and linkage to care. Methods This is …

it (code pays fourni par la source)

Virological outcomes of PWH who discontinued cabotegravir/rilpivirine long-acting therapy in a real-world context

Roberta Gagliardini, Alessandro Tavelli, Valentina Mazzotta, Angelo Roberto Raccagni et autres

OBJECTIVES: The aim of this study was to describe virological outcomes in people with HIV (PWH) after discontinuation of long-acting (LA) cabotegravir (CAB) plus rilpivirine (RPV). METHODS: All PWH enrolled in the Icona Cohort who discontinued CAB/RPV LA and had at least …

it, us (code pays fourni par la source)

Implementation of HIV pre-exposure prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE cohort survey

Silvia Nozza, Thomas Masoero, Alessandro Tavelli, Filippo Leserri et autres

OBJECTIVES: Italy introduced reimbursement for oral HIV pre-exposure prophylaxis (PrEP) in 2023. We examined PrEP implementation in Italy from 2023 to 2024 to evaluate regional uptake. METHODS: A nationwide survey within the scope of the PrIDE cohort (NCT07186244) was conducted across 62 …

it, us, gr, il (code pays fourni par la source)

How we treat Nocardia infections in transplant recipients and people with HIV

Margherita Pieruzzi, Tommaso Matucci, Angelo Roberto Raccagni, Spinello Antinori et autres

it (code pays fourni par la source)

Management of asymptomatic bacterial STIs and doxycycline postexposure prophylaxis: consensus statement of the Italian Society of Infectious and Tropical Diseases

Silvia Nozza, Pietro Vinti, Andrea Giacomelli, Valentina Mazzotta et autres

it (code pays fourni par la source)

Antimicrobial use for the treatment of bacterial sexually transmitted infections among doxycycline post-exposure prophylaxis (DoxyPEP) users in Milan, Italy—right-to-reply

Angelo Roberto Raccagni, Antonella Castagna, Silvia Nozza

We thank Kenyon for his thoughtful comments on our analysis of antimicrobials use among DoxyPEP users in Milan.1 We agree on two important points. Firstly, further data on the effectiveness of DoxyPEP in preventing symptomatic infections, as well as data on antibiotic …

it (code pays fourni par la source)

A Humoral Dilemma: Reassessing Monkeypox Virus Neutralizing Antibodies at More Than 2 Years From Mpox or Modified Vaccinia Ankara-Bavarian Nordic Vaccination

Nicolò Moschetta, Elena Criscuolo, Angelo Roberto Raccagni, Nicolò Capra et autres

BACKGROUND: The persistence of immunological memory after immunization against monkeypox virus (MPXV) is unclear. This study assessed MPXV-specific neutralizing antibodies (nAbs) at > 2 years from mpox or Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccination. METHODS: Retrospective study including individuals with previous mpox …

it (code pays fourni par la source)

Routine HIV RNA Testing During Injectable Cabotegravir and Oral Preexposure Prophylaxis Use

Angelo Roberto Raccagni, Riccardo Lolatto, Elena Bruzzesi, Camilla Muccini et autres

Angelo Roberto Raccagni, Riccardo Lolatto, Elena Bruzzesi, Camilla Muccini, Antonella Castagna, Silvia Nozza; Routine HIVRNA Testing During Injectable Cabo

it (code pays fourni par la source)

TelePrEP in Italy: A remote service to expand equitable access to HIV pre‐exposure prophylaxis

Maria Luisa Cosmaro, S Penon, F Falzetta, Caterina Candela et autres

INTRODUCTION: HIV pre-exposure prophylaxis (PrEP) access still appears to be disproportionate, with existing barriers. This study aims to describe the characteristics, retention and feasibility of TelePrEP, Italy's first remote PrEP service, which was launched in February 2023 to address inequities in PrEP …

it (code pays fourni par la source)